ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Masashi Komeda
D. Craig Miller
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glasson, J. R.
Right arrow Articles by Miller, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glasson, J. R.
Right arrow Articles by Miller, D. C.
Related Collections
Right arrowRelated Article

Ann Thorac Surg 1996;62:1059-1067
© 1996 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Three-Dimensional Dynamics of the Canine Mitral Annulus During Ischemic Mitral Regurgitation

Julie R. Glasson, MD, Masashi Komeda, MD, PhD, George T. Daughters, II, MS, Ann F. Bolger, MD, Andrew MacIsaac, MD, Stephen N. Oesterle, MD, Neil B. Ingels, Jr, PhD, D. Craig Miller, MD

Department of Cardiovascular and Thoracic Surgery and Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford; and Cardiac Surgery and Cardiology Sections, Department of Veterans Affairs Medical Center, and Department of Cardiovascular Physiology and Biophysics, Research Institute of the Palo Alto Medical Foundation, Palo Alto, California


    Abstract
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Background. It has been suggested that ischemic mitral regurgitation results, at least in part, from generalized end-systolic mitral annulus (MA) dilatation, but the role of the MA is incompletely understood and the segmental dynamics of the MA during left ventricular ischemia have not been described.

Methods. We used radiopaque markers and simultaneous biplane videofluoroscopy to measure three-dimensional in vivo lengths of eight MA segments in 7 sedated dogs before and after induction of ischemic MR (produced by circumflex coronary artery balloon occlusion and verified by Doppler echocardiography). As viewed from the left atrium, the MA segment between markers 1 and 2 (S12) was defined as starting at the posteromedial commissure, and remaining segments were numbered sequentially clockwise around the MA (ie, the posterior MA encompassed S12, S23, S34, S45; the anterior MA included S56, S67, S78, S81). Marker images obtained 7 to 12 days after implantation were used to construct x, y, and z coordinates of each marker at end-diastole and end-systole.

Results. During regional (posterolateral walls) left ventricular ischemia, the end-systolic MA area increased (4.9 ± 0.8 cm2 [control] versus 5.9 ± 0.6 cm2; p = 0.005). End-systolic MA segment lengths were as follows (control, ischemia [mm, mean ± standard deviation]): S12 = 9 ± 2, 10 ± 3; S23 = 10 ± 2, 12 ± 3; S34 = 13 ± 1, 15 ± 1; S45 = 8 ± 2, 9 ± 2; S56 = 11 ± 2, 11 ± 2; S67 = 12 ± 2, 12 ± 2; S78 = 10 ± 3, 11 ± 2; and S81 = 11 ± 1, 12 ± 1. Values for S12, S23, S34, and S81 were significant (p <= 0.05 for control versus ischemia by paired t test).

Conclusions. During ischemic mitral regurgitation, the MA enlarged at end-systole, but in an asymmetric manner; most posterior annular segments lengthened, whereas most anterior annular segment lengths did not change. These data suggest that alterations in regional MA mechanics may be important in the pathogenesis of ischemic mitral regurgitation. Further three-dimensional studies of MA dynamics and shape should be conducted so that new knowledge may result in improved mitral valve surgical techniques.


    Introduction
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
See also page 1067.

Ischemic mitral regurgitation (MR) is a common entity, with up to 19% of patients having some degree of MR when evaluated for coronary artery disease after myocardial infarction [1]. Some of these patients experience progressive, moderate or severe MR over the ensuing months or years, and many ultimately require operative intervention. At present, the preferred operative treatment of ischemic MR is mitral valve repair when feasible [2], frequently including ring annuloplasty [3, 4], even though the role of the mitral annulus (MA) in the pathogenesis of ischemic MR is incompletely understood. Previous reports have suggested that ischemic MR results, at least in part, from generalized end-systolic MA dilatation [5, 6], but segmental MA dynamics during myocardial ischemia have not been described. To date, studies of MA motion (using cinefluoroscopy of lead beads sutured to the MA [7] or echocardiography to image the MA [8, 9]) have been limited by the inability to define and track the motion of discrete sites on the mitral apparatus in three-dimensional (3-D) space.

In this experiment (using the same cohort of animals as in a previous study [10]), circumflex coronary artery balloon occlusion was used to induce acute ischemic MR to assess the effects of acute posterolateral left ventricular (LV) ischemia and resultant MR on MA dynamics. We used myocardial marker technology [11] to measure in vivo changes in 3-D regional MA size and shape occurring throughout the cardiac cycle. The dynamics of the MA during posterolateral LV ischemia and MR were compared with those during preischemic control conditions.


    Material and Methods
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Surgical Preparation
Seven healthy adult mongrel dogs (30 ± 5 kg) of either sex were premedicated with acepromazine (0.01 to 0.05 mg/kg intramuscularly) and atropine sulfate (0.05 mg/kg intravenously [IV]), anesthetized with sodium thiopental (25 mg/kg IV), intubated, and placed on artificial ventilation (Ohio Anesthesia Ventilator, Madison, WI). General anesthesia was maintained with inhalational isoflurane 1% to 2.2% and supplemental oxygen. A micromanometer-tipped pressure transducer (SPC-500; Millar Instruments, Inc, Houston, TX) was zeroed in 37°C water and inserted into the left femoral artery to monitor systemic arterial pressure. A left thoracotomy was performed through the fifth intercostal space, and superior and inferior vena caval pneumatic occluders (In Vivo Metric Systems, Healdsburg, CA) were placed to allow transient reductions in preload. The heart was suspended in a pericardial cradle, and miniature tantalum radiopaque helices (internal diameter, 0.8 mm; outer diameter, 1.3 mm; length, 1.5 to 3.0 mm; with some having different small extensions or "tails" to facilitate subsequent radiographic identification) were inserted into the LV wall and septum. The markers were placed on the obturator of a modified spinal needle (20 gauge), inserted through a stab wound in the epicardial surface, and deposited in the subepicardium by withdrawal of the obturator from the sheath. Eight markers were placed in the LV subepicardium along four equally spaced longitudinal LV meridians in the anterior wall (origin of the left anterior descending coronary artery to the apex), lateral wall (obtuse margin), posterior wall (inferior wall along the posterior descending coronary artery), and septal wall (Fig 1Go). Each meridian contained markers at two levels, in the basal-equatorial and apical-equatorial planes. A ninth marker was placed at the LV apex. Epicardial echocardiographic guidance was used to place the septal markers at the desired sites on the right ventricular endocardial side of the septum. This marker arrangement permitted visualization of the LV silhouette in both the 45-degree right anterior oblique and the 45-degree left anterior oblique videofluoroscopic projections.



View larger version (21K):
[in this window]
[in a new window]
 
Fig 1. . Array of the nine subepicardial markers in the left ventricle. The eight mitral annular marker numbers are also shown.

 
After LV marker placement, the animal was given heparin (300 IU/kg IV), and cardiopulmonary bypass was instituted using a roller pump (Pemco, Cleveland, OH) and a bubble oxygenator (Harvey H-1300; Bard Cardiopulmonary, Santa Ana, CA). A 14F or 16F arterial cannula was inserted into the right femoral artery, and a two-stage venous cannula was inserted into the right atrium and inferior vena cava. The ascending aorta was cross-clamped, and the heart was arrested with antegrade cold cardioplegia.

The left atrial appendage was opened. Eight miniature tantalum radiopaque markers were sutured at equal distances around the circumference of the MA (see Fig 1Go, Fig 2Go), one near each commissure (markers 1 and 5) and three along the perimeters of the anterior (markers 6 to 8) and posterior (markers 2 to 4) leaflets. An implantable Konigsberg micromanometer pressure transducer (P4.5-X6; Konigsberg Instruments, Inc, Pasadena, CA) was placed in the LV chamber through the apex for subsequent LV pressure measurements. The heart was rewarmed, the left atriotomy was closed, the aortic cross-clamp was released, and the animal was weaned from cardiopulmonary bypass. Heparin was reversed with protamine, and the pericardium was loosely reapproximated. To reduce immediate postoperative pain, we performed an intercostal block (20 mL 0.25% bupivacaine) at the fourth, fifth, and sixth intercostal spaces. Chest tubes were placed, transducer leads and occluder tubes were exteriorized, and the incision was closed. Oxymorphone hydrochloride (Numorphan, 0.05 to 0.2 mg/kg IV; DuPont Merck Pharma, Manatic, Puerto Rico) was given as needed to minimize incisional discomfort, and the animals recovered in the intensive care unit of the Stanford University Department of Laboratory Animal Medicine.



View larger version (19K):
[in this window]
[in a new window]
 
Fig 2. . The eight-marker array on the mitral annulus, as viewed from the left atrium. Marker numbers (squares) together with segment numbers (S) are shown. The region of aortic-mitral continuity overlaps S67.

 
Experimental Protocol
After 9 ± 2 (mean ± standard deviation) days, the dog was taken to the experimental animal cardiac catheterization laboratory for hemodynamic and videofluorographic data acquisition. Mild sedation was accomplished with diazepam (5 mg IV) and supplemental ketamine (5 mg/kg IV), administered as needed. A micromanometer-tipped catheter (Millar SPC-500) zeroed in a 37°C water bath was advanced through a left femoral artery cutdown (performed under local anesthesia with 1% lidocaine) into the ascending aorta for aortic pressure monitoring. To minimize the reflex sympathetic and parasympathetic responses that occur in conscious animals, we accomplished autonomic blockade with esmolol (0.25 to 0.4 mg • kg-1 • min-1 IV infusion, titrated to reduce the heart rate below 120 beats/min) and atropine sulfate (0.02 to 0.04 mg/kg IV). UL-FS49 (Boehringer-Ingelheim, Ridgefield, CT—a highly specific negative chronotropic agent that does not change the QT interval, inotropic state, or systolic or diastolic blood pressure [12]—was administered (4 to 6 mg IV, single dose) as needed to lower the heart rate further. Such heart rate reduction was necessary to facilitate subsequent cinefluoroscopic visualization and tracking of marker motion.

An 8-F Powerbase coronary guiding catheter (Advanced Cardiovascular Systems, Inc, Temecula, CA) was advanced into the left main coronary artery over a 0.014-in hi-torque floppy guidewire (Advanced Cardiovascular Systems, Inc) through the 8F left femoral artery sheath. A conventional 3.5-mm nonperfusion balloon dilation catheter was then advanced through the guiding catheter into the proximal left circumflex coronary artery (in 6 dogs) or into a large posterior descending branch (1 dog). Balloon size was selected to be fully occlusive. The balloon was inflated to 6 atm, with complete occlusion of the selected artery in all cases. The balloon was kept inflated for 2 to 3 minutes, producing acute myocardial ischemia in the posterolateral LV walls and resulting in ischemic MR. Ischemic MR was verified and graded by a single observer as none, mild to moderate, or moderate to severe using transthoracic Doppler echocardiography.

Data were obtained with the hearts in normal sinus rhythm, except for one (dog 7), which was atrially paced at 120 beats/min secondary to atrioventricular dissociation. Hemodynamic and biplane videofluoroscopic data recordings were obtained during steady-state conditions and over a physiologic range of peak LV systolic pressures during vena caval occlusion immediately before and after coronary artery balloon occlusion. The dogs were allowed to stabilize for 3 to 5 minutes between data acquisitions. Any sequences containing premature ventricular contractions were discarded and subsequently repeated.

All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 85-23, revised 1985). This study was approved by the Stanford Medical Center Laboratory Research Animal Review Committee and was conducted according to Stanford University policy.

Data Acquisition
All imaging studies were conducted with the animal in the right lateral decubitus position using a Philips Optimus 2000 biplane Lateral ARC 2/Poly DIAGNOST C2 system (Philips Medical Systems, North America Co, Pleasanton, CA) with the image intensifiers in the 7-in fluoroscopic mode. The 45-degree right anterior oblique and 45-degree left anterior oblique biplane fluoroscopic images were recorded simultaneously on two Sony U-Matic 5800 3/4-in video cassette recorders (Sony Corp, Japan). The analog LV pressure signal was recorded in digital format on each individual video image using a customized intelligent video controller (Grey Engineering Corp, Los Angeles, CA); the electrocardiographic (ECG) R wave was detected electronically and encoded digitally on the videotape as an end-diastolic timing marker. At the completion of the study, images of 1-cm grids and biplane images of a 3-D helical phantom of known dimensions were recorded to determine radiographic distortion and magnification factors. The 2-D coordinates of each marker in each projection were digitized frame by frame using semiautomated customized image-processing and digitization software developed in our laboratory [13] and run on a microcomputer system (Hewlett-Packard RS/20, Palo Alto, CA; equipped with Matrox MVP/AT/NP image-processing boards, Dorval, Quebec, Canada). Data from the two views were corrected for x-ray magnification and distortion, and right anterior oblique and left anterior oblique marker coordinates were merged using custom software as described previously [14] to yield 3-D coordinates of each marker every 16.7 milliseconds.

During data acquisition, two channels of analog data (LV pressure and surface lead ECG) were acquired and digitized simultaneously at 240 Hz using a microcomputer (486-33; JDR Microdevices Inc, San Jose, CA) with a high-speed data-acquisition card (DT 3831-G; Data Translation Inc, Marlboro, MA) controlled by data-acquisition software (Labtech Control 3.2.0; Laboratory Technology Corp, Wilmington, MA). These analog signals also were simultaneously recorded on a multichannel recorder (580CDR/16; Vidco Inc, Beaverton, OR) at a paper speed of 25 mm/s. The 240-Hz pressure data were merged with the 60-Hz marker-derived geometry data, aligning the LV pressure signals (or ECG R waves) from the two sources by calculating and minimizing a convolution of the 240-Hz and 60-Hz signals to be matched.

Data Analysis
Data from three consecutive steady-state beats during both preischemic control and ischemic MR conditions were averaged and analyzed as control and ischemia data, respectively.

HEMODYNAMIC INDICES.
To minimize the effects of intrathoracic pressure variation, we used only end-expiratory beats for analysis. The time derivative of the LV pressure signal was used to determine peak positive LV dP/dt (dP/dtmax) and peak negative LV dP/dt (-dP/dtmax). For each cardiac cycle, the time of end-diastole (ED) was defined as the videofluoroscopic frame containing the ECG R wave, and end-systole (ES) was defined as the videofluoroscopic frame immediately before the frame that contained the point of maximum negative LV dP/dt.

LEFT VENTRICULAR VOLUME.
Instantaneous LV volume was calculated with a multiple elliptic cylinder/cone model [15]. The eight LV epicardial markers, eight MA markers, and one apical marker (see Fig 1Go) define three cross-sectional marker layers from base to apex (annular, basal-equatorial, and apical-equatorial). The LV volume was computed as the sum of the volumes of two elliptic cylinders (between the annular and basal-equatorial layers, and the basal-equatorial and apical-equatorial layers) and one elliptic cone (between the apical-equatorial layer and the apex). This computed volume included both the myocardial volume and the volume of the blood contained within the LV chamber. We have previously shown that changes in this computed volume accurately reflect changes in LV chamber volume [16]. These volume differences were sufficient for our present purposes; we did not attempt to estimate absolute LV chamber volume in this study.

SYSTOLIC LEFT VENTRICULAR FUNCTION.
Systolic performance was assessed as LV end-systolic elastance, measured from the end-systolic pressure-volume relation [17]. We determined LV end-systolic pressure (Pes) and volume (Ves) instantaneously during preload reduction using an iterative computer algorithm to define the end-systolic pressure-volume relation [18]. Least-squares linear regression was used to fit a line of the form: Pes = Ees (Ves - V0) to these end-systolic points, where Ees and V0 are the slope and volume axis intercept, respectively.

MITRAL ANNULAR DYNAMICS.
Segmental lengths between adjacent MA markers were computed from the 3-D MA marker coordinates at ED and ES. Percentage systolic shortening for each segment was calculated as ([Led - Les]/Led) • 100%, where Led and Les are end-diastolic and end-systolic segment lengths; negative values indicate systolic lengthening. The MA area and perimeter were also computed from the 3-D marker coordinates, without assuming circular or planar geometry. The MA perimeter was calculated as the sum of the eight contiguous segments (see Fig 2Go). The MA area was computed as the summation of six triangular areas derived from triplets of MA marker coordinates. Percentage changes for area and perimeter were calculated as ([Aed - Aes]/Aed) • 100% and ([Ced - Ces]/Ced) • 100%, where Aed and Aes are end-diastolic and end-systolic areas, and Ced and Ces are end-diastolic and end-systolic perimeters.

MITRAL ANNULAR SHAPE.
A cylindric coordinate system was defined with the origin at the midpoint of the chord joining the commissural markers (markers 1 and 5), and with the negative z-axis directed through the LV apical marker. The z-axis coordinate of each MA marker was calculated at ED and ES. Using this system, positive z coordinates were toward the left atrium, and negative z coordinates were toward the LV apex.

STATISTICAL ANALYSIS.
All data are reported as mean ± 1 standard deviation. The MA area, perimeter, and segmental length measurements at ED and ES were compared using Student's t test for paired observations, for both preischemic control and ischemic MR conditions independently. The MA marker z coordinates during control and ischemic conditions were compared using Student's t test for paired observations. Evaluation of segmental length changes was also performed using two-way analysis of variance with segment number and presence of myocardial ischemia as independent variables, and with dog ID as a dummy variable to control for interanimal variability. When indicated by a significant F statistic (p <= 0.05), specific segmental differences were examined using the Bonferroni correction for multiple comparisons.


    Results
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Postmortem examination of the excised hearts revealed all LV epicardial markers to be within 1 mm of the epicardial surface. All eight annular markers were within 1 mm of the MA, as defined by the mitral leaflet–left atrial junction.

Hemodynamic Indices
Mitral regurgitation, assessed by echocardiography, was successfully induced in all 7 dogs; 5 dogs had mild to moderate MR and 2 dogs had moderate to severe MR. None of the dogs had evidence of MR before balloon occlusion of the circumflex coronary artery.

The mean heart rate for all dogs did not differ significantly between preischemic control (105 ± 18 beats/min) and ischemic MR conditions (106 ± 16 beats/min). With ischemia, the ejection fraction fell from 0.22 ± 0.04 during control conditions to 0.15 ± 0.03 (p < 0.005); LV end-diastolic pressure increased from 21 ± 6 to 32 ± 6 mm Hg (p = 0.005); LV stroke work decreased from 3,640 ± 464 to 1,970 ± 465 mm Hg • mL (p < 0.001); LV dP/dtmax decreased from 1,610 ± 307 to 1,234 ± 344 mm Hg/s (p < 0.001); and Ees decreased from 2.3 ± 0.4 to 1.4 ± 0.3 mm Hg/mL (p = 0.001).

Mitral Annular Dynamics
Figure 3Go shows the typical changes in MA area and perimeter from one heart throughout the cardiac cycle, during both the preischemic control and ischemic MR conditions. The MA orifice size was larger during ischemic MR than during control conditions throughout the entire cardiac cycle. For the 7 dogs, the mean ischemic MA area was 15% ± 14% larger at ED but 21% ± 13% larger at ES, and the mean MA perimeter was 7% ± 6% larger at ED and 9% ± 6% larger at ES, as compared with control values (Fig 4Go). Figure 3Go also shows that systolic MA orifice reduction still occurred during ischemic MR. For the group, from ED to ES, the MA area decreased 14% ± 9% (5.7 ± 0.8 to 4.9 ± 0.8 cm2; p < 0.005) during the control condition and 10% ± 3% (6.5 ± 0.6 to 5.9 ± 0.6 cm2; p < 0.001) during ischemic MR (p = not significant, control versus ischemia); the MA perimeter decreased 6% ± 4% (8.9 ± 0.6 to 8.3 ± 0.6 cm; p < 0.01) during the control condition and 4% ± 1% (9.5 ± 0.4 to 9.1 ± 0.4 cm; p < 0.001) during ischemic MR (p = not significant, control versus ischemia).



View larger version (26K):
[in this window]
[in a new window]
 
Fig 3. . Representative preischemic control (solid line) and ischemic mitral regurgitation (dashed line) data from three cardiac cycles from one heart, demonstrating the changes in mitral annulus (MA) area and perimeter versus x-ray frame number (1 frame = 16.7 milliseconds). The period of left ventricular ejection (ejection) lies between the electrocardiographic R-wave marker (end-diastole) on the left and the maximum negative dP/dt minus one frame (end-systole) on the right.

 


View larger version (60K):
[in this window]
[in a new window]
 
Fig 4. . Mitral annulus end-diastolic and end-systolic area and perimeter for preischemic control (open bars) and ischemic mitral regurgitation (striped bars) conditions. Data are mean area (cm2) and mean perimeter (cm) for all dogs, with error bars representing 1 standard deviation. (*p <= 0.01 and #p <= 0.02, control versus ischemia, by Student's t test for paired observations.)

 
Analysis of variance demonstrated that the MA segment number (ie, anatomic location) and the presence of regional LV ischemia were both important determinants of MA segment length (p < 0.005). Table 1Go summarizes the ED segment lengths, and Table 2Go the ES segment lengths, during control and ischemic MR conditions for all dogs. As can be seen from Table 1Go, all eight MA segments at ED were somewhat longer than control lengths during ischemic MR, although only the elongation in MA segments S34, S45, S67, and S81 reached statistical significance (p <= 0.05, control versus ischemia). However, the changes from control measurements in MA segment lengths at ES during ischemic MR occurred in a more distinct pattern. Table 2Go reveals that ES MA enlargement during ischemic MR was not symmetric; the posterior annular segments lengthened significantly (S12, S23, and S34), whereas the length of all anterior MA segments (except for one segment [S81] contiguous with the posterior MA) did not change. This asymmetric ES MA enlargement during ischemic MR is shown graphically in Figure 5Go.


View this table:
[in this window]
[in a new window]
 
Table 1. . Mitral Annular Segment Lengths at End-Diastolea
 

View this table:
[in this window]
[in a new window]
 
Table 2. . Mitral Annular Segment Lengths at End-Systolea
 


View larger version (24K):
[in this window]
[in a new window]
 
Fig 5. . Projection of the mitral annulus and eight annular markers in the z = zero plane, as viewed from the left atrium at end-diastole and end-systole, for preischemic control (dashed line) and ischemic mitral regurgitation (solid line) conditions. Data are group mean marker positions (mm), with the origin at the intercommissural midpoint (between markers 1 and 5). The posterior annulus is to the right and the anterior annulus is to the left. The region of aortic-mitral continuity overlaps the segment between markers 6 and 7.

 
Figure 6Go demonstrates the group mean percentage systolic shortening of each segment during control and ischemic MR conditions. The greatest shortening from ED to ES occurred in the region of the midposterior MA (S34), during both control (18% ± 5%, p <= 0.001 versus zero) and ischemic MR (11% ± 4%, p <= 0.001 versus zero) conditions. This systolic shortening of S34 was significantly less during ischemic MR (p < 0.01 versus control). As can be seen in Figure 6Go, S67, which overlaps the region of aortic-mitral continuity, lengthened from ED to ES during control conditions (-7% ± 7%, p <= 0.01 versus zero), as reported recently from this laboratory [10]; moreover, this S67 lengthening during LV ejection continued even in the presence of posterolateral LV ischemia and MR (p = not significant, control versus ischemia).



View larger version (22K):
[in this window]
[in a new window]
 
Fig 6. . Percentage systolic shortening (from end-diastole to end-systole) for all eight mitral annulus segments (S) for preischemic control (solid line) and ischemic mitral regurgitation (dashed line) conditions. Data are mean percentage shortening for each segment (negative values indicate lengthening), with error bars representing 1 standard deviation (*p <= 0.05 versus zero; #p <= 0.001 versus zero; +p <= 0.01, control versus ischemia; by Student's t test for paired observations.)

 
Mitral Annular Shape
In addition to segmental length changes, the z coordinates of each MA marker at ED and ES were compared during both control and ischemic MR conditions to assess this one component of MA shape change. Figures 7 and 8GoGo show the MA marker positions along the z-axis at ED and ES during control and ischemic MR conditions, respectively; the anterior MA sites had positive z coordinates and the posterior MA sites had negative z coordinates, indicating a "tilted saddle" shape [10, 19, 20]. This shape was generally maintained during ischemic MR, but certain significant differences occurred. At ED (see Fig 7Go), the posterior MA (markers 1, 2, and 3) had significantly greater negative z values during ischemic MR than during control conditions, but the height of the anterior MA, or "saddlehorn" (markers 6 and 7), did not change significantly. At ES (see Fig 8Go), however, the anterior MA "saddlehorn" had significantly smaller positive z values during ischemic MR compared with control conditions (p <= 0.01 for markers 6 and 7, control versus ischemia), indicating a reduction in height of the MA in the area of aortic-mitral continuity. This lowered height at ES of the anterior MA "saddlehorn" region during ischemic MR is shown in Figure 9Go.



View larger version (17K):
[in this window]
[in a new window]
 
Fig 7. . Mitral annulus marker positions (z coordinates) at end-diastole for preischemic control (solid line) and ischemic mitral regurgitation (dashed line) conditions. Data are mean marker position (mm), with error bars representing 1 standard deviation. (*p <= 0.02 and #p <= 0.001, control versus ischemia, by Student's t test for paired observations.)

 


View larger version (17K):
[in this window]
[in a new window]
 
Fig 8. . Mitral annulus marker positions (z coordinates) at end-systole for preischemic control (solid line) and ischemic mitral regurgitation (dashed line) conditions. Data are mean marker position (mm), with error bars representing 1 standard deviation (*p <= 0.02 and #p <= 0.005, control versus ischemia, by Student's t test for paired observations.)

 


View larger version (32K):
[in this window]
[in a new window]
 
Fig 9. . Three-dimensional reconstruction of the mitral annulus and eight annular markers in the anterior-posterior projection at end-diastole and end-systole, for preischemic control (dashed line) and ischemic mitral regurgitation (solid line) conditions. Data are mean marker positions (mm), with the origin at the intercommissural midpoint (between markers 1 and 5). Negative values along the ordinate are toward the left ventricular apex. The posterior annulus is to the right and the anterior annulus is to the left.

 

    Comment
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
In this study, we used myocardial marker technology to compare the in vivo 3-D MA size and shape changes during acute posterolateral LV ischemia and resultant MR with those during preischemic control conditions in sedated, closed-chest dogs.

Hemodynamic Indices
All data were obtained from healthy adult dogs in normal sinus rhythm (except for dog 7, which was atrially paced throughout data collection, as noted previously) during autonomic blockade with esmolol and atropine sulfate. The proximal circumflex coronary artery was occluded to induce ischemic MR in 6 dogs; dog 7 had a large posterior descending coronary artery branch that was occluded successfully to induce ischemic MR. The hemodynamic indices for dog 7 were not statistically different from those of the other study animals; therefore, the data presented include all 7 study animals. Substantial LV ischemia was produced in all dogs, as verified by ECG ST-segment elevations, an increase in LV end-diastolic pressure, and decreases in ejection fraction, LV stroke work, LV dP/dtmax, and Ees.

Mitral Annular Dynamics
The area and perimeter of the MA orifice increased during acute ischemia and attendant MR as compared with control measurements. This enlargement was present at both time points in the cardiac cycle (see Fig 3Go), but enlargement at ES was greater than that at ED for both indices. In addition, the enlargement was not symmetric; at ES, the posterior MA segments were longer during ischemia, whereas most of the anterior MA segments did not change length (see Table 2Go, Fig 5Go). This finding of nonhomogeneous annular enlargement is consistent with recent observations in sheep [21]. Such asymmetric enlargement may be explained by the MA anatomic architecture. The posterior part of the MA is interposed between the myocardium of the left atrium and ventricle, being supported only by muscle [22], whereas the anterior MA contains the area of aortic-mitral continuity and bridges the left and right fibrous trigones. Therefore, one intuitively would think that the anterior MA is less likely to dilate [23].

Our current finding that the MA area and perimeter during acute ischemic MR were relatively larger at ES than at ED implies that systolic contraction of the MA or the contiguous LV myocardium was impaired during regional ischemia, as suggested by previous investigators [24]. Even though Figure 3Go shows that MA shrinkage continued to occur from ED to ES during ischemic MR, regional analysis revealed that systolic shortening was significantly less in the midposterior MA region (see Fig 6Go, S34). Such a reduction in posterior MA segmental systolic shortening, alone or in combination with MA dilatation, may be an instrumental factor in the genesis of MR secondary to posterolateral LV ischemia [25, 26].

Anterior MA segmental systolic length changes were generally preserved during ischemic MR. As we reported previously [10], the part of the MA overlapping the area of aortic-mitral continuity (S67) actually lengthened from ED to ES; the current study demonstrated that this anterior MA segmental systolic lengthening is still present during ischemic MR (see Fig 6Go). Thus, although posterior MA shortening during LV ejection was reduced during ischemic MR, lengthening of the anterior MA during LV ejection persisted. The mechanism responsible for this systolic lengthening of S67 is unknown; we have postulated that this may be due to traction forces exerted by contraction of the surrounding basal LV fibers [10]. Further investigations using anterior LV ischemia may define more precisely the mechanism of this anterior MA systolic lengthening.

Mitral Annular Shape
We have previously described the MA shape in normal canine hearts as resembling a "tilted saddle," with the "saddlehorn" of the MA located near the area of aortic-mitral continuity (markers 6 and 7) [10]; this shape was also seen in the current study (see Figs 7–9GoGoGo). Although anterior MA systolic lengthening was preserved during ischemic MR, acute posterolateral LV ischemia resulted in a significant reduction in the height of the anterior MA "saddlehorn" near the aortic valve at ES (see Figs 8, 9GoGo), as assessed by the MA marker z positions. This upward displacement (relative to the LV) of the anterior MA toward the left atrium during systole may provide a path that minimizes resistance to outflow during LV ejection. Thus, acute posterolateral LV regional ischemia, in addition to limiting the extent of posterior MA systolic shortening, modified the overall MA shape. If resistance to LV outflow were increased by this change in anterior MA shape, it could potentially augment the severity of MR. Fluid dynamic studies of LV-chamber blood flow patterns, both with and without regional LV ischemia and MR, are needed to define more clearly the implications of MA shape changes.

Surgical Implications
These data reveal that the ES MA enlargement associated with acute posterolateral LV ischemia and MR is due primarily to posterior MA lengthening, with the majority of the anterior MA segments maintaining their functional integrity. Hence, patients with inferior LV ischemia and resultant MR might benefit most from a posterior annuloplasty, thereby not interfering with anterior MA motion. Although anterior MA shape was perturbed by acute regional LV ischemia in this study, fixation of the anterior MA would eliminate systolic lengthening in the region of aortic-mitral continuity. In fact, van Rijk-Zwikker and associates [27] reported that a stiff anterior MA (after rigid ring insertion) was pushed beneath the aortic valve during systole, resulting in mild subvalvular obstruction to LV outflow. Furthermore, a flexible ring, rather than a rigid one, may help maintain continuous physiologic MA mobility throughout the cardiac cycle [28]. David and colleagues [29] reported that LV systolic pump performance (as assessed by LV pressure-volume as well as stroke volume–end-diastolic volume relations) early after mitral valve reconstruction for chronic MR was enhanced in patients with flexible rather than rigid annuloplasty rings, although this may have been a transient phenomenon because no major difference was seen after 1 year [29]. This hemodynamic benefit may, in part, have to do with maintaining the flexibility of the entire MA, especially portions of the anterior MA. Before contemplating modification of our current clinical techniques, however, further 3-D investigations of fixation of specific parts of the MA, both with and without ischemic MR (generated by posterior as well as anterior regional LV ischemia), are needed to elucidate the importance of MA shape and mobility.

Limitations
This experiment was designed to study solely the alterations in regional MA dynamics that occur during acute posterolateral LV ischemia with resultant MR. Our observations revealed that posterior MA elongation and impaired systolic shortening, as well as altered anterior MA shape, may contribute to the MR resulting from posterolateral LV ischemia. This study did not address other factors (such as papillary muscle dysfunction or LV shape changes [21, 25, 30]) that may also play a role in the development of ischemic MR. Furthermore, the degree of MR was not quantified in this study; Doppler echocardiography was used to grade MR subjectively as none, mild to moderate, or moderate to severe. Ongoing experiments in our laboratory using aortic flow probes in conjunction with markers to calculate the mitral regurgitant fraction have been designed to investigate further the pathogenesis of ischemic MR.

The use of myocardial markers for 3-D assessment of cardiac dynamics allows accurate and reproducible determination of marker position, with a mean overall error of 0.1 ± 0.6 mm every 16.7 milliseconds [14]. The length of a segment of the MA between two adjacent markers was estimated by a chord, however, rather than the actual arc length of the segment. The error in estimating arc length by using chord length (for a sector angle of 45 degrees, the ideal in this case) is -2.5%, and this value is virtually constant between ED and ES. Thus, we estimate that the percentage changes in segmental lengths reported here are within 0.2% of what the actual arc lengths would be.

The animals in this study had normal hearts but were autonomically blocked to control heart rate and to avoid the influence of reflex responses. Because of the autonomic blockade, the hearts studied had depressed LV systolic function, and it is possible that they also had subnormal systolic MA motion. However, each animal served as its own control, and the dose of esmolol remained constant throughout the study. Furthermore, the calculated LV ejection fractions (0.22 ± 0.04 and 0.15 ± 0.03) are based on epicardial marker motion and therefore do not take into account LV wall thickening, which represents a major proportion of LV chamber volume reduction during ejection. Nevertheless, it is probable that the relative changes between control and ischemic conditions might be more pronounced in unblocked animals.

This experiment was conducted in dogs, which have been reported to have a greater muscular component to the cardiac endoskeleton than humans [7]. The findings of the current study, therefore, may not be totally applicable to patients, particularly those with dilated hearts and markedly limited LV systolic function, eg, in the setting of chronic MR. In addition, because regional ischemia was associated with decreased LV performance (as indicated by significant reductions in LV ejection fraction, stroke work, dP/dtmax, and Ees during ischemia), it is possible that the MR observed in this study was also due in part to changes in LV function and geometry, which may have contributed to incomplete mitral leaflet coaptation. Further 3-D studies of mitral leaflet motion, LV geometry, and MA dynamics in other animal models, both with and without ischemic MR, are clearly needed to confirm the present findings, as well as to define more clearly other mechanisms contributing to the pathogenesis of ischemic MR. We are currently using an ovine model to address some of these issues.


    Acknowledgments
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
This work was supported by grants HL-29589 and HL-48837 from the National Heart, Lung and Blood Institute, and the Veterans Administration Medical Research Service. Doctors Glasson and Komeda are Carl and Leah McConnell Cardiovascular Surgical Research Fellows. Doctor Glasson was also supported by The Thoracic Surgery Foundation Research Fellowship Award.

We gratefully acknowledge Mary K. Zasio, BA, Carol W. Mead, BA, Erin M. Schultz, BS, and Geraldine C. Derby, RN, for their technical expertise in surgical preparation, data acquisition, and data reduction; Terrence L. Tye, MS, for his help with intraoperative epicardial echocardiography; and Phoebe E. Taboada, BA, for her help in preparing the manuscript and figures.


    Footnotes
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 
Presented at the Thirty-second Annual Meeting of The Society of Thoracic Surgeons, Orlando, FL,Jan 29–31, 1996.

Address reprint requests to Dr Miller, Department of Cardiovascular and Thoracic Surgery, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, CA 94305-5247.


    References
 Top
 Footnotes
 Abstract
 Introduction
 Material and Methods
 Results
 Comment
 Acknowledgments
 References
 

  1. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 1988;78(Suppl 1):51–9.
  2. Hendren WG, Nemec JJ, Lytle BW, et al. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 1991;52:1246–52.[Abstract]
  3. Dion R. Ischemic mitral regurgitation: when and how should it be corrected? J Heart Valve Dis 1993;2:536–43.[Medline]
  4. Oury JH, Cleveland JC, Duran CG, Angell WW. Ischemic mitral valve disease: classification and systemic approach to management. J Cardiac Surg 1994;9(Suppl):262–73.
  5. Stewart WJ, Currie PJ, Salcedo EE, et al. Evaluation of mitral leaflet motion by echocardiography and jet direction by Doppler color flow mapping to determine the mechanism of mitral regurgitation. J Am Coll Cardiol 1992;20:1353–61.[Abstract]
  6. Rankin SJ. Improving surgical strategies for ischemic mitral regurgitation. J Heart Valve Dis 1993;2:533–5.[Medline]
  7. Tsakiris AG, von Bernuth G, Rastelli GC, Bourgeois MJ, Titus JL, Wood EH. Size and motion of the mitral valve annulus in anesthetized intact dogs. J Appl Physiol 1971;30:611–8.[Free Full Text]
  8. Ormiston JA, Shah PM, Tei C, Wong M. Size and motion of the mitral valve annulus in man: a two-dimensional echocardiographic method and findings in normal subjects. Circulation 1981;64:113–20.[Abstract/Free Full Text]
  9. Toumandis ST, Sideris DA, Papamichael CM, Moulopoulos SD. The role of mitral annulus motion in left ventricular function. Acta Cardiol 1992;47:331–48.[Medline]
  10. Glasson JR, Komeda M, Daughters GT, Bolger AF, Ingels NB, Miller DC. Three-dimensional regional dynamics of the normal mitral annulus during left ventricular ejection. J Thorac Cardiovasc Surg 1999;111:574–85.
  11. Ingels NB, Daughters GT, Stinson EB, Alderman EL. Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers. Circulation 1975;52:859–67.[Abstract/Free Full Text]
  12. Schipke JD, Harasawa Y, Sugiura S, Alexander J, Burkhoff D. Effect of a bradycardic agent on the isolated blood-perfused canine heart. Cardiovasc Drugs Ther 1991;5:481–8.[Medline]
  13. Niczyporuk MA, Miller DC. Automatic tracking and digitization of multiple radiopaque myocardial markers. Comput Biomed Res 1991;24:129–42.[Medline]
  14. Daughters GT, Sanders WJ, Miller DC, Schwarzkopf A, Mead CW, Ingels NB. A comparison of two analytical systems for three-dimensional reconstruction from biplane videoradiograms. Proc Comput Cardiol (IEEE) 1989;15:79–82.
  15. Yun KL, Rayhill SC, Niczyporuk MA, et al. Mitral valve replacement in dilated canine hearts with chronic mitral regurgitation: importance of the mitral subvalvular apparatus. Circulation 1991;84(Suppl 3):112–24.
  16. Moon MR, Castro LJ, Derby GC, et al. Calculation of biventricular volume: myocardial marker vs. sonomicrometric shell subtraction technique [Abstract]. Circulation 1992;86:I553.
  17. Sagawa K. The end-systolic pressure-volume relation of the ventricle: definition, modifications and clinical use. Circulation 1981;63:1223–7.[Free Full Text]
  18. Kono A, Maughan WL, Sunagawa K, Hamilton K, Sugawa K, Weisfeldt ML. The use of left ventricular end-ejection pressure and peak pressure in the estimation of the end-systolic pressure-volume relationship. Circulation 1984;70:1057–65.[Abstract/Free Full Text]
  19. Levine RA, Handschumacher MD, Sanfilippo AJ, et al. Three-dimensional echocardiographic reconstruction of the mitral valve, with implications for the diagnosis of mitral valve prolapse. Circulation 1989;80:589–98.[Abstract/Free Full Text]
  20. Pai RG, Tanimoto M, Jintapakorn W, Azevedo J, Pandian NG, Shah PM. Volume-rendered three-dimensional dynamic anatomy of the mitral annulus using a transesophageal echocardiographic technique. J Heart Valve Dis 1995;4:623–7.[Medline]
  21. Gorman RC, McCaughan JS, Ratcliffe MB, et al. Pathogenesis of acute ischemic mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg 1995;109:684–93.[Abstract/Free Full Text]
  22. Walmsley R. Anatomy of human mitral valve in adult cadaver and comparative anatomy of the valve. Br Heart J 1978;40:351–66.[Free Full Text]
  23. van Rijk-Zwikker GL, Delemarre BJ, Huysmans HA. Mitral valve anatomy and morphology: relevance to mitral valve replacement and valve reconstruction. J Cardiac Surg 1994;9(Suppl):255–61.
  24. Perloff JK, Roberts WC. The mitral apparatus: functional anatomy of mitral regurgitation. Circulation 1972;46:227–39.[Abstract/Free Full Text]
  25. Kaul S, Spotnitz WD, Glasheen WP, Touchstone DA. Mechanism of ischemic mitral regurgitation: an experimental evaluation. Circulation 1991;84:2167–80.[Abstract/Free Full Text]
  26. Chandraratna PAN, Aronow WS. Mitral valve ring in normal vs. dilated left ventricle. Chest 1981;79:151–4.[Abstract/Free Full Text]
  27. van Rijk-Zwikker GL, Mast F, Schipperheyn JJ, Huysmans HA, Bruschke AVG. Comparison of rigid and flexible rings for annuloplasty of the porcine mitral valve. Circulation 1990;82(Suppl 4):58–64.
  28. Yamauara Y, Yoshikawa J, Yoshida K, Hozumi T, Akasaka T, Okada Y. Three-dimensional analysis of configuration and dynamics in patients with an annuloplasty ring by multiplane transesophageal echocardiography: comparison between flexible and rigid annuloplasty rings. J Heart Valve Dis 1995;4:618–22.[Medline]
  29. David TE, Komeda M, Pollick C, Burns RJ. Mitral valve annuloplasty: the effect of the type on left ventricular function. Ann Thorac Surg 1989;47:524–8.[Abstract]
  30. Llaneras MR, Nance ML, Streicher JT, et al. Pathogenesis of ischemic mitral insufficiency. J Thorac Cardiovasc Surg 1993;105:439–43.[Abstract]

Related Article

Discussion
Ann. Thorac. Surg. 1996 62: 1067-1068. [Extract] [Full Text]



This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
J. Kwan, G.-C. Kim, M.-J. Jeon, D.-H. Kim, T. Shiota, J. D. Thomas, K.-S. Park, and W.-H. Lee
3D geometry of a normal tricuspid annulus during systole: A comparison study with the mitral annulus using real-time 3D echocardiography
Eur J Echocardiogr, October 1, 2007; 8(5): 375 - 383.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Coghlan and J. Hoffman
Leonardo da Vinci's flights of the mind must continue: cardiac architecture and the fundamental relation of form and function revisited
Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S4 - S17.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
J. X. Qin, T. Shiota, H. Tsujino, G. Saracino, R. D. White, N. L. Greenberg, J. Kwan, Z. B. Popovic, D. A. Agler, W. J. Stewart, et al.
Mitral annular motion as a surrogate for left ventricular ejection fraction: real-time three-dimensional echocardiography and magnetic resonance imaging studies
Eur J Echocardiogr, December 1, 2004; 5(6): 407 - 415.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. M. Parish, B. M. Jackson, Y. Enomoto, R. C. Gorman, and J. H. Gorman III
The Dynamic Anterior Mitral Annulus
Ann. Thorac. Surg., October 1, 2004; 78(4): 1248 - 1255.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Gorman III, B. M. Jackson, S. L. Moainie, Y. Enomoto, and R. C. Gorman
Influence of inotropy and chronotropy on the mitral valve sphincter mechanism
Ann. Thorac. Surg., March 1, 2004; 77(3): 852 - 857.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. Torrent-Guasp, M. J. Kocica, A. Corno, M. Komeda, J. Cox, A. Flotats, M. Ballester-Rodes, and F. Carreras-Costa
Systolic ventricular filling
Eur. J. Cardiothorac. Surg., March 1, 2004; 25(3): 376 - 386.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. A. Tibayan, F. Rodriguez, F. Langer, M. K. Zasio, L. Bailey, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller
Annular remodeling in chronic ischemic mitral regurgitation: ring selection implications
Ann. Thorac. Surg., November 1, 2003; 76(5): 1549 - 1555.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Kwan, T. Shiota, D. A. Agler, Z. B. Popovic, J. X. Qin, M. A. Gillinov, W. J. Stewart, D. M. Cosgrove, P. M. McCarthy, and J. D. Thomas
Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation: Real-Time Three-Dimensional Echocardiography Study
Circulation, March 4, 2003; 107(8): 1135 - 1140.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Otsuji, T. Kumanohoso, S. Yoshifuku, K. Matsukida, C. Koriyama, A. Kisanuki, S. Minagoe, R. A. Levine, and C. Tei
Isolated annular dilation does not usually cause important functional mitral regurgitation: Comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy
J. Am. Coll. Cardiol., May 15, 2002; 39(10): 1651 - 1656.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. R. Green, P. Dagum, J. R. Glasson, G. T. Daughters, A. F. Bolger, L. E. Foppiano, G. J. Berry, N. B. Ingels Jr, and D. C. Miller
Mitral Annular Dilatation and Papillary Muscle Dislocation Without Mitral Regurgitation in Sheep
Circulation, November 9, 1999; 100(90002): II-95 - 102.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Enriquez-Sarano, A.-J. Basmadjian, A. Rossi, K. R. Bailey, J. B. Seward, and A. J. Tajik
Progression of mitral regurgitation: A prospective Doppler echocardiographic study
J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1137 - 1144.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. R. Glasson, M. Komeda, G. T. Daughters, A. F. Bolger, M. O. Karlsson, L. E. Foppiano, M. Hayase, S. N. Oesterle, N. B. Ingels Jr., and D. C. Miller
Early systolic mitral leaflet "loitering" during acute ischemic mitral regurgitation
J. Thorac. Cardiovasc. Surg., August 1, 1998; 116(2): 193 - 205.
[Abstract] [Full Text] [PDF]